November 12th, 2012
Nine Italian Cardiologists Arrested in Broad Investigation of Research Fraud and Misconduct
Larry Husten, PHD
Nine Italian cardiologists have been arrested as part of a broad investigation into serious medical misconduct at Modena Hospital, according to multiple reports in the Italian media. The investigation encompasses at least 67 other individuals and a dozen medical equipment companies, including 6 foreign companies. The charges include conspiracy, fraud, embezzlement, bribery, forgery, and performing […]
November 7th, 2012
Statins Use Linked to Reduction in Cancer Mortality
Larry Husten, PHD
A large new study raises the possibility that statin use may lead to a decline in cancer mortality. Researchers in Denmark used health data from the entire population of the country and analyzed the information from nearly 300,000 patients who were diagnosed with cancer between 1995 and 2007. The authors note that the relationship is biologically […]
November 7th, 2012
Closing Remarks from AHA
Amit Shah, MD, MSCR
On his return home, a fellow wraps up his AHA.12 experience.
November 7th, 2012
Better Evidence, More Comparators Needed in Device Research
Sanjiv Shah, MD
Rita Redberg expands on her research letter in the current JAMA critiquing the lack of good comparative effectiveness data for new, high-risk medical devices.
November 7th, 2012
Science, with a Little Bit of Flash
Tariq Ahmad, MD, MPH
At a stirring Late-Breaking Clinical Trials session when researchers present possibly ground-breaking research, a fellow wonders what happens behind the scenes.
November 7th, 2012
Risk Prediction and Translation to Clinical Practice
Amit Shah, MD, MSCR
Are we focusing too much on risk prediction of CVD? Or not enough?
November 6th, 2012
Poster Sessions: Better to Present or Observe?
Eiman Jahangir, MD
A fellow presents his poster to a few people but finds more fulfillment in interacting with other poster presenters.
November 6th, 2012
Ultrafiltration Fails to Show Benefit in Acute Heart Failure
Larry Husten, PHD
Although ultrafiltration (UF) in recent years has become increasingly popular as an alternative to intravenous diuretics for patients with acute decompensated heart failure with acute cardiorenal syndrome (type 1), the first clinical trial to test its value shows that it is inferior to standard drug therapy. The results of CARRESS-HF (Cardiorenal Rescue Study in Acute Decompensated […]
November 6th, 2012
A New Era in ICD Therapy — Get with the Programming!
Arthur J. Moss, MD
The principal investigator of the MADIT-RIT trial comments on the clinical implications of his study group’s research.
November 6th, 2012
RELAX-AHF Stirs Interest in Novel Drug for Acute Heart Failure
Larry Husten, PHD
A new drug modeled on a hormone active in pregnancy may prove beneficial to patients with acute decompensated heart failure. Serelaxin is a recombinant form of human relaxin-2, which is known to mediate the hemodynamic changes that occur during pregnancy. The drug is under development by Novartis for use in acute heart failure. In the […]
NEJM Journal Watch — Recent Cardiology Articles- Aficamten for Obstructive Hypertrophic Cardiomyopathy
- Obicetrapib and Cardiovascular Outcomes: Early Insights
- Statin Use in Pregnancy and Risk of Congenital Malformations
- More Data to Guide Anticoagulation After Ablation for Atrial Fibrillation
- Is Mavacamten Effective for Nonobstructive Hypertrophic Cardiomyopathy?